GlassScriptPhysician profile
Fiona Shehaj
NPI 1861757932
$5,332.69
in general payments reported to CMS, 2019-2025
37 companies · $772 in 2025
The $772 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $912 · 2020: $1,091 · 2021: $626 · 2022: $555 · 2023: $672 · 2024: $706 · 2025: $772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,149.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $645.62 | 2019-2025 | |
| Medtronic Vascular, INC. | $466.27 | 2019-2020 | |
| Amgen INC. | $455.79 | 2019-2025 | Repatha |
| Abiomed | $350.57 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $345.60 | 2019-2024 | Xarelto |
| Abbott Laboratories | $296.09 | 2021-2023 | Mitraclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $228.24 | 2019-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $222.99 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $194.88 | 2021-2024 | Jardiance |
| Medtronic, INC. | $191.71 | 2022-2025 | Cg Future, Corevalve Evolut R, Onyx Frontier |
| E.R. Squibb & Sons, L.L.C. | $174.42 | 2019-2022 | |
| Heartflow, INC. | $169.01 | 2022-2025 | |
| Inari Medical, INC. | $146.60 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novo Nordisk INC | $145.95 | 2020-2025 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $145.02 | 2021-2024 | Verquvo |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fiona Shehaj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.